Show simple item record

dc.contributor.authorCarnie, Lindsay E
dc.contributor.authorFarrell, Kelly
dc.contributor.authorBarratt, Natalie
dc.contributor.authorAbraham, Marc
dc.contributor.authorGillespie, Loraine
dc.contributor.authorSatyadas, T.
dc.contributor.authorMcNamara, Mairead G
dc.contributor.authorHubner, Richard A
dc.contributor.authorGeraghty, J.
dc.contributor.authorBibby, N.
dc.contributor.authorValle, Juan W
dc.contributor.authorLamarca, Angela
dc.date.accessioned2022-01-11T12:00:11Z
dc.date.available2022-01-11T12:00:11Z
dc.date.issued2021en
dc.identifier.citationCarnie LE, Farrell K, Barratt N, Abraham M, Gillespie L, Satyadas T, et al. Pancreatic Enzyme Replacement Therapy for Patients Diagnosed With Pancreaticobiliary Cancer Vol. 50, Pancreas. Ovid Technologies (Wolters Kluwer Health); 2021. p. 1254–9.en
dc.identifier.pmid34860808en
dc.identifier.doi10.1097/mpa.0000000000001906en
dc.identifier.urihttp://hdl.handle.net/10541/624969
dc.titlePancreatic enzyme replacement therapy for patients diagnosed with pancreaticobiliary cancer validation of an algorithm for dose escalation and managementen
dc.typeArticleen
dc.contributor.departmentFrom the Nutrition and Dietetics Medical Oncology, The Christie NHS Foundation Trust.en
dc.identifier.journalPancreasen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record